139 related articles for article (PubMed ID: 32744836)
1. Use of multiple potency assays to evaluate human mesenchymal stromal cells.
Christy BA; Herzig MC; Delavan CP; Abaasah I; Cantu C; Salgado C; Lovelace S; Garcia L; Jensen K; Montgomery R; Cap AP; Bynum JA
J Trauma Acute Care Surg; 2020 Aug; 89(2S Suppl 2):S109-S117. PubMed ID: 32744836
[TBL] [Abstract][Full Text] [Related]
2. Human mesenchymal stromal cell source and culture conditions influence extracellular vesicle angiogenic and metabolic effects on human endothelial cells in vitro.
Chance TC; Herzig MC; Christy BA; Delavan C; Rathbone CR; Cap AP; Bynum JA
J Trauma Acute Care Surg; 2020 Aug; 89(2S Suppl 2):S100-S108. PubMed ID: 32176171
[TBL] [Abstract][Full Text] [Related]
3. Human primary fibroblasts perform similarly to MSCs in assays used to evaluate MSC safety and potency.
Christy BA; Herzig MC; Delavan C; Cantu C; Salgado C; Bynum JA; Cap AP
Transfusion; 2019 Apr; 59(S2):1593-1600. PubMed ID: 30980752
[TBL] [Abstract][Full Text] [Related]
4. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
[TBL] [Abstract][Full Text] [Related]
5. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
[TBL] [Abstract][Full Text] [Related]
6. Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel®, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product.
Thej C; Ramadasse B; Walvekar A; Majumdar AS; Balasubramanian S
Stem Cell Res Ther; 2017 Feb; 8(1):47. PubMed ID: 28245882
[TBL] [Abstract][Full Text] [Related]
7. Influence of Donor's Age on Immunomodulatory Properties of Canine Adipose Tissue-Derived Mesenchymal Stem Cells.
Taguchi T; Borjesson DL; Osmond C; Griffon DJ
Stem Cells Dev; 2019 Dec; 28(23):1562-1571. PubMed ID: 31588862
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8(+) T cell proliferation by human mesenchymal stromal cells.
Hong J; Hueckelhoven A; Wang L; Schmitt A; Wuchter P; Tabarkiewicz J; Kleist C; Bieback K; Ho AD; Schmitt M
Cytotherapy; 2016 May; 18(5):621-9. PubMed ID: 27008974
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta.
Du WJ; Chi Y; Yang ZX; Li ZJ; Cui JJ; Song BQ; Li X; Yang SG; Han ZB; Han ZC
Stem Cell Res Ther; 2016 Nov; 7(1):163. PubMed ID: 27832825
[TBL] [Abstract][Full Text] [Related]
10. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
Zimmermann JA; McDevitt TC
Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
13. Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls.
Menard C; Pacelli L; Bassi G; Dulong J; Bifari F; Bezier I; Zanoncello J; Ricciardi M; Latour M; Bourin P; Schrezenmeier H; Sensebé L; Tarte K; Krampera M
Stem Cells Dev; 2013 Jun; 22(12):1789-801. PubMed ID: 23339531
[TBL] [Abstract][Full Text] [Related]
14. Exosomes Derived from Hypoxia-Treated Human Adipose Mesenchymal Stem Cells Enhance Angiogenesis Through the PKA Signaling Pathway.
Xue C; Shen Y; Li X; Li B; Zhao S; Gu J; Chen Y; Ma B; Wei J; Han Q; Zhao RC
Stem Cells Dev; 2018 Apr; 27(7):456-465. PubMed ID: 29415626
[TBL] [Abstract][Full Text] [Related]
15. Preconditioning with interleukin-1 beta and interferon-gamma enhances the efficacy of human umbilical cord blood-derived mesenchymal stem cells-based therapy via enhancing prostaglandin E2 secretion and indoleamine 2,3-dioxygenase activity in dextran sulfate sodium-induced colitis.
Yu Y; Yoo SM; Park HH; Baek SY; Kim YJ; Lee S; Kim YL; Seo KW; Kang KS
J Tissue Eng Regen Med; 2019 Oct; 13(10):1792-1804. PubMed ID: 31293088
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
[TBL] [Abstract][Full Text] [Related]
17. Identification and Evaluation of New Immunoregulatory Genes in Mesenchymal Stromal Cells of Different Origins: Comparison of Normal and Inflammatory Conditions.
Fayyad-Kazan M; Najar M; Fayyad-Kazan H; Raicevic G; Lagneaux L
Med Sci Monit Basic Res; 2017 Mar; 23():87-96. PubMed ID: 28336906
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity.
Zhang Z; Han Y; Song J; Luo R; Jin X; Mu D; Su S; Ji X; Ren YF; Liu H
J Oral Pathol Med; 2015 Jan; 44(1):15-27. PubMed ID: 25212102
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow donor selection and characterization of MSCs is critical for pre-clinical and clinical cell dose production.
Trivedi A; Miyazawa B; Gibb S; Valanoski K; Vivona L; Lin M; Potter D; Stone M; Norris PJ; Murphy J; Smith S; Schreiber M; Pati S
J Transl Med; 2019 Apr; 17(1):128. PubMed ID: 30995929
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory and immunogenic properties of mesenchymal stem cells derived from bovine fetal bone marrow and adipose tissue.
Huaman O; Bahamonde J; Cahuascanco B; Jervis M; Palomino J; Torres CG; Peralta OA
Res Vet Sci; 2019 Jun; 124():212-222. PubMed ID: 30925336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
